会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明专利
    • Preparation of l-aspartic acid
    • L-阿片酸的制备
    • JPS59113895A
    • 1984-06-30
    • JP21299882
    • 1982-12-03
    • Tanabe Seiyaku Co Ltd
    • SENHATA ICHIROUKIZUMI MASAHIKONISHIMURA NORIYUKI
    • C12P13/20C12R1/185
    • C12P13/20
    • PURPOSE: To prepare L-aspartic acid in high efficiency, by using a microbial strain having high aspartase activity and prepared by the mutagenic treatment of microorganism belonging to Escherichia genus.
      CONSTITUTION: A microbial strain belonging to Escherichia genus and having aspartase activity, e.g. Escherichia coli ATCC 11303, is subjected to the conventional mutagenic treatment to obtain a mutant growing in a medium containing L-aspartic acid as sole nitrogen source or nitrogen and carbon source and having high aspartase activity, e.g. Escherichia coli EAPC-28 (FERM-BP 388) is cultured, and the cultured liquid, cultured microbial cells or treated cells are brought into contact with fumaric acid and ammonia.
      COPYRIGHT: (C)1984,JPO&Japio
    • 目的:通过使用具有高天冬氨酸活性并通过诱变处理大肠埃希菌属微生物制备的微生物菌株,高效地制备L-天冬氨酸。 构成:属于埃希氏菌属并具有天冬氨酰酶活性的微生物菌株,例如, 对大肠杆菌ATCC11303进行常规诱变处理以获得在含有L-天冬氨酸作为唯一氮源或氮源和碳源并且具有高天冬氨酸酶活性的培养基中生长的突变体,例如, 培养大肠杆菌EAPC-28(FERM-BP388),使培养的液体,培养的微生物细胞或经处理的细胞与富马酸和氨接触。
    • 10. 发明专利
    • Preparation of l-aspartic acid
    • L-阿片酸的制备
    • JPS59113887A
    • 1984-06-30
    • JP21588982
    • 1982-12-08
    • Tanabe Seiyaku Co Ltd
    • SENHATA ICHIROUKIZUMI MASAHIKONISHIMURA NORIYUKI
    • C12N1/20C12P13/20C12R1/425
    • C12R1/43C12P13/20
    • PURPOSE: To prepare L-aspartic acid, in high efficiency, by using a novel microbial strain having high aspartase activity and release catabolyte repression, and prepared by the mutagenic treatment of microorganism belonging to Serratia genus.
      CONSTITUTION: A microbial strain belonging to Serratia genus, having aspartase activity and sensitive to catabolyte repression, e.g. Serratia marcescens 800 is subjected to the mutagenic treatment by conventional means, and cultured in a medium containing L-aspartic acid as the sole nitrogen source or nitrogen and carbon source. The obtained novel microbial strain having high aspartase activity and released catabolyte repression, e.g. Serratia marcescens AP
      c -494 (FERM-BP 392), the culture liquid obtained by the cultivation of said microbial strain, the cultured cell, or treated cell, is made to contact with fumaric acid and ammonia.
      COPYRIGHT: (C)1984,JPO&Japio
    • 目的:通过使用具有高天冬氨酸酶活性和释放多巴胺降解抑制作用的新型微生物菌株,并通过诱变处理沙雷氏菌属微生物制备高效率L-天冬氨酸。 构成:属于沙雷氏菌属的微生物菌株,具有天冬氨酰胺酶活性并对嗜碱性蛋白酶抑制敏感。 粘质沙雷氏菌800通过常规方法进行诱变处理,并在含有L-天冬氨酸作为唯一氮源或氮和碳源的培养基中培养。 获得的具有高天冬氨酸酶活性和释放的克拉酵母抑制的新型微生物菌株,例如, 将粘质沙雷氏菌APc-494(FERM-BP 392),将通过培养所述微生物菌株,培养细胞或经处理的细胞获得的培养液与富马酸和氨接触。